Type 2 diabetes in adults: management (medicines update)Status:In developmentProgramme:NICE guidelineExpected publication date: 18 February 2026
Teplizumab for delaying the onset of stage 3 type 1 diabetes in people 8 years and over with stage 2 type 1 diabetes [ID6259]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 8 April 2026
Insulin efsitora alfa for treating type 2 diabetes ID6499Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 22 October 2026
Cardiometabolic disease prevention and treatment guidelinesStatus:In developmentProgramme:NICE HubExpected publication date: TBC
Insulin efsitora alfa for treating type 1 diabetes in people on multiple daily insulin injections [ID6498]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Tirzepatide for treating type 2 diabetes in people 10 to 17 years [ID6539]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Zimislecel for treating type 1 diabetes in people 12 years and over with impaired hypoglycaemic awareness and severe hypoglycaemia [ID6624]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Semaglutide for treating type 2 diabetes in people 10 to 17 years [TSID12249]Status:Topic prioritisationProgramme:Technology appraisal guidanceExpected publication date: TBC
Dasiglucagon for treating severe hypoglycaemia caused by type 1 diabetes in people under 6 years [TSID12255]Status:Topic prioritisationProgramme:Technology appraisal guidanceExpected publication date: TBC
Diabetes in pregnancy: management from preconception to the postnatal period - Managing type 1 diabetes (T1D) using hybrid closed loops (update)Status:In developmentProgramme:NICE guidelineExpected publication date: TBC
Digital flexor tenotomy for diabetic footStatus:Topic prioritisationProgramme:Interventional procedures guidanceExpected publication date: TBC